A ninth repratriation

Thanks to the Reverse the Brain Drain program, the Institut du cancer de Montréal actively pursues the recruitment of Quebec clinicians who left to practice medicine abroad. As part of this program, we welcomed Dr. Saima Hassan into our ranks in 2016.   

Dr. Saima Hassan is an oncologist surgeon, researcher, and assistant professor at the Université de Montréal. 

Born in Montreal, Dr. Saima Hassan holds a diploma from the Faculty of Medicine and General Surgery at McGill University. She completed a PhD in translational research on diagnostic and prognostic markers in the context of breast cancer metastases. She went on to complete a fellowship in general surgery for oncology, with a focus on breast cancer and melanomas. She went through three years of postdoctoral research studying the pre-clinical role of PARP inhibitors in triple-negative breast cancer at the Oregon Health and Science University in Portland, Oregon. Dr. Hassan also carried out clinical activities in breast cancer under the supervision of Dr. André Robidoux. Dr. Hassan’s main focus is breast cancer.  


Reverse the brain drain


In 2007, the Reverse the Brain Drain program was born in order to combat the loss of trained individuals, which was perceived as a threat to the Montreal scientific community’s ability to flourish. This program, initiated by the Institut du cancer de Montréal, has allowed us to repatriate nine high-level researchers who were pursuing their careers abroad. Not only did these researchers come to the CRCHUM as part of the Institut du cancer de Montréal, they also brought their expertise on maximizing grants received through this program and standing out in provincial and national grant competitions. Dr. Saima Hassan joined the team in 2016 (see below).

The Institut du cancer de Montréal’s board of directors has been pleased with the success of the repatriated researchers, as it demonstrates in a concrete manner that they made a judicious choice of candidates and that they deserve the trust that the Institut granted them in providing start-up funds in the amount of $250 000 to support these researchers during their first five years back in Montreal.